Agios to Participate in December Investor Conference
CAMBRIDGE, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism pioneering therapies for rare diseases, today announced that the company is scheduled to present at the Bank of America 2022 Virtual Biotech SMID Cap Conference on Wednesday, December 7, 2022, at 11:25 a.m. ET.
A live webcast of the presentations can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios.com. A replay of the webcast will be archived on the Agios website for at least two weeks following the presentation.
Investor and Media Contact:
Beyond the Office â€“ Managing the Agent Experience
Future of Work Expo #TECHSUPERSHOW Networking Live Party - Sponsored by Comcast, Spectrum Partner Program, Cox Communications, Connectwise, C3 Complete, Telesystem, Glasshive, Optimum Business, GFI Software